USPTO serial 88777788
SEPTICYTE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- May 31, 2022
- Examiner
- SOBRAL, CHRISTINA
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with SEPTICYTE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Boonah, Queensland, AU
Boonah, Queensland, AU
Boonah, Queensland, AU
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Leigh Ann Lindquist
Leigh Ann Lindquist SUGHRUE MION, PLLC2000 Pennsylvania Avenue NW, Suite 9000Washington, DC 20006UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Biological chemical test kits for medical laboratory use in analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression, immune disorders, for diagnosis and treatment of sepsis | ACTIVE | — |
| 005 | Clinical diagnostics for medical or veterinary use; biological chemical test kits comprised of medical diagnostic reagents and assays for medical laboratory use in analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression, immune disorders | ACTIVE | — |
| 010 | Surgical and medical apparatus and instruments for use in analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression, immune disorders; peripheral blood or immune cell diagnostic test apparatus for analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression, immune disorders; diagnostic testing kits in this class consisting primarily of probes, buffers and reagents for use in microbial testing; point of care medical devices, namely, devices using nucleic acid amplification in the nature of real-time polymerase chain reaction or isothermal amplification, DNA sequencing or analyte quantification in the nature of mass spectrometry, protein array for analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression, immune disorders | ACTIVE | — |
| 044 | Medical services; medical pathology services; medical pathology services being the analysis of body fluid samples; medical services being molecular diagnostic services and taking of body fluid samples of others; providing information, advisory and consultancy services in relation to medical services, medical pathology services, the analysis of body fluid samples, medical services being molecular diagnostic services and taking of body fluid samples of others | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by ImmuneXpress Pty Ltd
- Other trademarks owned by ImmuneXpress Pty Ltd
- Other trademarks owned by ImmuneXpress Pty Ltd
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 044
- Similar marks named SEPTICYTE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 31, 2022 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| May 31, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 15, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 15, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 23, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 8, 2022 | OTHE | CASE RETURNED TO EXAMINATION | — |
| Feb 8, 2022 | IUCN | NOTICE OF ALLOWANCE CANCELLED | — |
| Feb 7, 2022 | ATRQ | ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED | — |
| Feb 7, 2022 | PCBG | PETITION TO DIRECTOR - CHANGE BASIS - GRANTED | — |
| Feb 3, 2022 | APET | ASSIGNED TO PETITION STAFF | — |
| Jan 21, 2022 | TPAD | TEAS PETITION TO AMEND BASIS RECEIVED | — |
| Dec 10, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 8, 2021 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Dec 8, 2021 | EXT2 | SOU EXTENSION 2 FILED | — |
| Dec 8, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 10, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 8, 2021 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jun 8, 2021 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jun 8, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 8, 2020 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Oct 13, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 13, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 23, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 7, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 7, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 7, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 7, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 7, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 17, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 17, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 17, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 17, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 12, 2020 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| Feb 12, 2020 | ALIE | ASSIGNED TO LIE | — |
| Feb 7, 2020 | ALIE | ASSIGNED TO LIE | — |
| Feb 4, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 3, 2020 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Feb 1, 2020 | NWAP | NEW APPLICATION ENTERED | — |